owais mohammad (47 Ergebnisse)

Zustand: New. New Book.

Hardcover. Zustand: New. Contents: 1. Evolution, Distribution and Cytogenetics. 2. Nursery Raising. 3. Cropping Systems. 4. Integrated Nutrient Management. 5. Integrated Pest Management. 6. Effect of Environmental Factors. 7. Manipulation of CO2, Light and Temperature for Vegetable Production. 8. Protected Seed Production. 9. Greenhouse Structures. 10. Soilless Culture. 11. Tilling as a Screening Tool. 12. Plant Ideotype Concept. 13. In-Vitro Conservation. 14. Somatic Hybridization. 15. Protoplast Culture and Fusion. 16. Seed Treatments and Seed Storage. 17. Seed Marketing, Demand Forecast and Marketing Organization. Over the past few decades, priority was given to achieve self-sufficiency in agricultural output. However, agricultural production has lagged far behind that of the services and manufacturing sectors in recent years, failing to keep pace with other economic sectors. Agriculture's share to GDP has declined sharply, despite continued reliance on the agricultural sector for subsistence. The Indian government has set a policy goal of doubling farmers' income by 2022. Farming expansion towards more remunerative enterprises, such as horticulture (fruits, vegetables, ornamentals etc.), cattle, and fish, was one of the key choices identified for raising farmers' earnings. Horticulture has a significant role to play in providing employment and income possibilities in India's north-western Himalayan states. Numerous geographical specificities that characterize the region create limits on increasing field crop output and providing revenue for smallholders. Vegetable crops such as Tomato, Brinjal, Potato, Chilly, Beet-root, Radish, Turnip, Carrot, Broccoli, Cabbage, Cauliflower, Knol Khol, Lettuce and many more have a lot of potential throughout the terrain. During the past decade tremendous advances have been achieved in various areas of crop improvement to achieve agricultural sustainability. In this regard, the present book has been brought out to highlight the recent progress achieved in vegetable cultivation methods with the advanced breeding and biotechnological interventions aiming sustainability in the production. This book delivers a convincing review accounting diverse aspects and progress towards the paradigm shift in vegetable growing. This book covers most of the syllabus topics for the M. Sc and Ph. D students studying in various agricultural institutes. The book provides comprehensive knowledge about the history of important vegetable crops and their evolution, distribution and cytogenetics, proper nursery raising techniques, different cropping systems, integrated nutrient and pest management, environmental effects affecting crops and their manipulation for vegetable production, vegetable seed production under protected cultivation, storage and treatments of seeds, various greenhouse structures, soilless vegetable growing, using biotechnological tools like "TILLING" for screening purposes and plant ideotyping, in-vitro conservation, somatic hybridization and protoplast culture and fusion technique.

Taschenbuch. Zustand: Neu. Trypanothione reductase: a potential anti-leishmanial drug target | Recent trend of development of drug resistant field isolates and usage of alternate drug targets as possible strategy for treatment of leishmaniasis | Mohammad Owais | Taschenbuch | Englisch | VDM Verlag Dr. Müller | EAN 9783639212440 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Zustand: New.

Zustand: New. In.

Zustand: New. In.

Zustand: Very Good.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. In.

Zustand: New.

Zustand: New.

Paperback. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Zustand: New.

Taschenbuch. Zustand: Neu. Combating Fungal Infections | Problems and Remedy | Iqbal Ahmad (u. a.) | Taschenbuch | xx | Englisch | 2014 | Springer | EAN 9783642446726 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Zustand: As New. Unread book in perfect condition.

Zustand: As New. Unread book in perfect condition.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 560 | Sprache: Englisch | Produktart: Bücher | Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.

Gebunden. Zustand: New. .Primariliy, this book is dedicated, but also highly recommended, to students, teachers and researchers enganged in universities, R&D insitutions, pharmaceutical or herbal industry, as well as health organizations. Advances in Food Sciences, 07/2007| Die.

Buch. Zustand: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.

Buch. Zustand: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.

Zustand: As New. Unread book in perfect condition.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated.

Zustand: New. pp. 560.

Buch. Zustand: Neu. Neuware - This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere.

Hardcover. Zustand: Brand New. 539 pages. 9.25x6.25x1.25 inches. In Stock.

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ahmad AnisAnis Ahmad, PhD is a CSIR-RA at the Interdisciplinary Biotechnology Unit AMU Aligarh India. Dr. Ahmad received his PhD in Biotechnology from the same institute in 2011. He has been teaching Molecular Microbiology for the la.

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Anjum ReshmaDr. Reshma Anjum is a former research scientist at Leibniz Institute (ATB), Germany and working at MT-Energie GmbH, Germany. Dr. Niclas Krakat is senior scientist and HOD of R&D at MT-Energie GmbH, Germany. Mohammad Owa.

Kartoniert / Broschiert. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Owais MohammadDr. M. Owais is holding faculty position at AMU, Aligarh. Leading edge advances include, development of nano-particle based formulations for the treatment of human leishmaniasis and other infectious diseases. Mukul K.